> top > docs > PubMed:28411266 > annotations

PubMed:28411266 JSONTXT

Annnotations TAB JSON ListView MergeView

test-210614

Id Subject Object Predicate Lexical cue proteinmutation
28411266_0 1276-1284 ProteinMutation denotes p.A1369S rs757110
28411266_1 929-937 ProteinMutation denotes p.A1369S rs757110
28411266_2 478-486 ProteinMutation denotes p.A1369S rs757110

PubTator4TogoVar

Id Subject Object Predicate Lexical cue proteinmutation
28411266_0 1276-1284 ProteinMutation denotes p.A1369S rs757110
28411266_1 929-937 ProteinMutation denotes p.A1369S rs757110
28411266_2 478-486 ProteinMutation denotes p.A1369S rs757110

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T5 655-924 Sentence denotes Using individual-level data from 120,286 participants in the UK Biobank and summary association results from four large-scale genome-wide association studies, we examined the impact of this variant on cardiometabolic traits, type 2 diabetes, and coronary heart disease.
T1 0-92 Sentence denotes Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease.
T2 93-242 Sentence denotes Despite widespread clinical use in the treatment of type 2 diabetes, the impact of sulfonylurea therapy on cardiovascular outcomes remains uncertain.
T3 243-382 Sentence denotes Studies of naturally occurring genetic variation can be used to anticipate the expected clinical consequences of a pharmacological therapy.
T4 383-654 Sentence denotes A common missense variant in the gene encoding a component of the sulfonylurea receptor (ABCC8 p.A1369S) promotes closure of the target channel of sulfonylurea therapy and is associated with increased insulin secretion, thus mimicking the effects of sulfonylurea therapy.
T6 925-1073 Sentence denotes The p.A1369S variant was associated with a significantly lower risk of type 2 diabetes (odds ratio [OR] 0.93; 95% CI 0.91, 0.95; P = 1.2 × 10(-11)).
T7 1074-1262 Sentence denotes The variant was associated with increased BMI (+0.062 kg/m(2); 95% CI 0.037, 0.086; P = 8.1 × 10(-7)) but lower waist-to-hip ratio adjusted for BMI, a marker of abdominal fat distribution.
T8 1263-1393 Sentence denotes Furthermore, p.A1369S was associated with a reduced risk of coronary heart disease (OR 0.98; 95% CI 0.96, 0.99; P = 5.9 × 10(-4)).
T9 1394-1550 Sentence denotes These results suggest that, despite a known association with increased weight, long-term sulfonylurea therapy may reduce the risk of coronary heart disease.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
12695 25-46 GeneOrGeneProduct denotes Sulfonylurea Receptor NCBIGene:6833
12696 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes MESH:D003924
12697 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease MESH:D003324
12698 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes MESH:D003924
12699 176-188 ChemicalEntity denotes sulfonylurea MESH:D013453
12700 449-470 GeneOrGeneProduct denotes sulfonylurea receptor NCBIGene:6833
12701 472-477 GeneOrGeneProduct denotes ABCC8 NCBIGene:6833
12702 478-486 SequenceVariant denotes p.A1369S DBSNP:rs757110
12703 530-542 ChemicalEntity denotes sulfonylurea MESH:D013453
12704 584-591 GeneOrGeneProduct denotes insulin NCBIGene:3630
12705 633-645 ChemicalEntity denotes sulfonylurea MESH:D013453
12706 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes MESH:D003924
12707 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease MESH:D003324
12708 929-937 SequenceVariant denotes p.A1369S DBSNP:rs757110
12709 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes MESH:D003924
12710 1276-1284 SequenceVariant denotes p.A1369S DBSNP:rs757110
12711 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease MESH:D003324
12712 1483-1495 ChemicalEntity denotes sulfonylurea MESH:D013453
12713 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease MESH:D003324

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 78-91 DiseaseOrPhenotypicFeature denotes Heart Disease 0005267
T2 910-923 DiseaseOrPhenotypicFeature denotes heart disease 0005267
T3 1332-1345 DiseaseOrPhenotypicFeature denotes heart disease 0005267
T4 1536-1549 DiseaseOrPhenotypicFeature denotes heart disease 0005267

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 478-486 SequenceVariant denotes p.A1369S
T2 929-937 SequenceVariant denotes p.A1369S
T3 1276-1284 SequenceVariant denotes p.A1369S

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 25-46 GeneOrGeneProduct denotes Sulfonylurea Receptor
T2 48-54 GeneOrGeneProduct denotes Type 2
T3 55-63 GeneOrGeneProduct denotes Diabetes
T4 78-83 GeneOrGeneProduct denotes Heart
T5 145-151 GeneOrGeneProduct denotes type 2
T6 152-160 GeneOrGeneProduct denotes diabetes
T7 166-172 GeneOrGeneProduct denotes impact
T8 392-400 GeneOrGeneProduct denotes missense
T9 449-470 GeneOrGeneProduct denotes sulfonylurea receptor
T10 472-477 GeneOrGeneProduct denotes ABCC8
T11 584-591 GeneOrGeneProduct denotes insulin
T12 592-601 GeneOrGeneProduct denotes secretion
T13 769-774 GeneOrGeneProduct denotes large
T14 830-836 GeneOrGeneProduct denotes impact
T15 872-878 GeneOrGeneProduct denotes traits
T16 880-886 GeneOrGeneProduct denotes type 2
T17 887-895 GeneOrGeneProduct denotes diabetes
T18 910-915 GeneOrGeneProduct denotes heart
T19 996-1002 GeneOrGeneProduct denotes type 2
T20 1003-1011 GeneOrGeneProduct denotes diabetes
T21 1186-1191 GeneOrGeneProduct denotes waist
T22 1235-1244 GeneOrGeneProduct denotes abdominal
T23 1245-1261 GeneOrGeneProduct denotes fat distribution
T24 1307-1314 GeneOrGeneProduct denotes reduced
T25 1332-1337 GeneOrGeneProduct denotes heart
T26 1375-1382 GeneOrGeneProduct denotes P = 5.9
T27 1473-1477 GeneOrGeneProduct denotes long
T28 1478-1482 GeneOrGeneProduct denotes term
T29 1508-1514 GeneOrGeneProduct denotes reduce
T30 1536-1541 GeneOrGeneProduct denotes heart

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 25-46 GeneOrGeneProduct denotes Sulfonylurea Receptor
T2 48-54 GeneOrGeneProduct denotes Type 2
T3 55-63 GeneOrGeneProduct denotes Diabetes
T4 78-83 GeneOrGeneProduct denotes Heart
T5 145-151 GeneOrGeneProduct denotes type 2
T6 152-160 GeneOrGeneProduct denotes diabetes
T7 166-172 GeneOrGeneProduct denotes impact
T8 449-470 GeneOrGeneProduct denotes sulfonylurea receptor
T9 472-477 GeneOrGeneProduct denotes ABCC8
T10 584-591 GeneOrGeneProduct denotes insulin
T11 769-774 GeneOrGeneProduct denotes large
T12 830-836 GeneOrGeneProduct denotes impact
T13 872-878 GeneOrGeneProduct denotes traits
T14 880-886 GeneOrGeneProduct denotes type 2
T15 887-895 GeneOrGeneProduct denotes diabetes
T16 910-915 GeneOrGeneProduct denotes heart
T17 996-1002 GeneOrGeneProduct denotes type 2
T18 1003-1011 GeneOrGeneProduct denotes diabetes
T19 1235-1244 GeneOrGeneProduct denotes abdominal
T20 1245-1261 GeneOrGeneProduct denotes fat distribution
T21 1307-1314 GeneOrGeneProduct denotes reduced
T22 1332-1337 GeneOrGeneProduct denotes heart
T23 1375-1382 GeneOrGeneProduct denotes P = 5.9
T24 1478-1482 GeneOrGeneProduct denotes term
T25 1536-1541 GeneOrGeneProduct denotes heart

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes D003924
T2 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease D003327
T3 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T4 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T5 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T6 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T7 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T8 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 25-46 GeneOrGeneProduct denotes Sulfonylurea Receptor
T2 449-470 GeneOrGeneProduct denotes sulfonylurea receptor
T3 472-477 GeneOrGeneProduct denotes ABCC8
T4 1245-1261 GeneOrGeneProduct denotes fat distribution
T5 1375-1382 GeneOrGeneProduct denotes P = 5.9

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes 0005148
T2 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease 0005010
T3 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes 0005148
T4 292-295 DiseaseOrPhenotypicFeature denotes can 0012833
T5 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes 0005148
T6 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease 0005010
T7 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes 0005148
T8 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease 0005010
T9 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease 0005010

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes D003924
T2 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease D003327
T3 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T4 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T5 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T6 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T7 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T8 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes D003924
T2 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease D003327
T3 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T4 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T5 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T6 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T7 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T8 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 25-37 ChemicalEntity denotes Sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831
T2 176-188 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_76983|http://purl.obolibrary.org/obo/CHEBI_26831
T4 449-461 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_76983|http://purl.obolibrary.org/obo/CHEBI_26831
T6 530-542 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_76983|http://purl.obolibrary.org/obo/CHEBI_26831
T8 633-645 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_76983|http://purl.obolibrary.org/obo/CHEBI_26831
T10 1483-1495 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_76983|http://purl.obolibrary.org/obo/CHEBI_26831

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T10 1483-1495 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831|http://purl.obolibrary.org/obo/CHEBI_76983
T8 633-645 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831|http://purl.obolibrary.org/obo/CHEBI_76983
T6 530-542 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831|http://purl.obolibrary.org/obo/CHEBI_76983
T4 449-461 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831|http://purl.obolibrary.org/obo/CHEBI_76983
T2 176-188 ChemicalEntity denotes sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831|http://purl.obolibrary.org/obo/CHEBI_76983
T1 25-37 ChemicalEntity denotes Sulfonylurea http://purl.obolibrary.org/obo/CHEBI_26831
T5 1375-1382 GeneOrGeneProduct denotes P = 5.9
T34673 1245-1261 GeneOrGeneProduct denotes fat distribution
T3 472-477 GeneOrGeneProduct denotes ABCC8
T77245 449-470 GeneOrGeneProduct denotes sulfonylurea receptor
T56263 25-46 GeneOrGeneProduct denotes Sulfonylurea Receptor
T84515 1527-1549 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T7 1323-1345 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T86714 996-1011 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T4049 901-923 DiseaseOrPhenotypicFeature denotes coronary heart disease D003327
T92003 880-895 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T76323 145-160 DiseaseOrPhenotypicFeature denotes type 2 diabetes D003924
T76869 69-91 DiseaseOrPhenotypicFeature denotes Coronary Heart Disease D003327
T56295 48-63 DiseaseOrPhenotypicFeature denotes Type 2 Diabetes D003924
T3532 1276-1284 SequenceVariant denotes p.A1369S
T71982 929-937 SequenceVariant denotes p.A1369S
T78896 478-486 SequenceVariant denotes p.A1369S